# CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia

> **NCT00272584** · PHASE4 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 100 (—)

## Conditions studied

- Psychosis, Schizophrenia

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00272584
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272584, "CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00272584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*